Is DOTS-Plus a feasible and cost-effective strategy?

Garner, Paul ORCID: https://orcid.org/0000-0002-0607-6941, Alejandria, M. and Lansang, M. A. (2006) 'Is DOTS-Plus a feasible and cost-effective strategy?'. PLoS Medicine, Vol 3, Issue 9, e350.

Preview

Text Plos_Medicine_3_9_e350.pdf - Published Version Available under License Creative Commons Attribution. Download (79kB) | Preview

Item Type:	Article
Subjects:	W General Medicine. Health Professions > W 74 Medical economics. Health care costs QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 268 Antitubercular agents. Antitubercular antibiotics QV Pharmacology > QV 38 Drug action. QW Microbiology and Immunology > QW 52 Physiology and chemistry of microorganisms. Metabolism. WA Public Health > WA 20.5 Research (General) WA Public Health > WA 30 Socioeconomic factors in public health (General) WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries WB Practice of Medicine > Therapeutics > WB 330 Drug therapy WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General) WF Respiratory System > Tuberculosis > WF 360 Drug therapy
Faculty: Department:	Groups (2002 - 2012) > International Health Group
Digital Object Identifer (DOI):	https://doi.org/10.1371/journal.pmed.0030350
Depositing User:	Martin Chapman
Date Deposited:	29 Mar 2011 17:43
Last Modified:	06 Sep 2019 10:14
URI:	https://archive.lstmed.ac.uk/id/eprint/1484

Statistics

View details

Actions (login required)

Edit Item